These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25047935)

  • 1. Design of granulatimide and isogranulatimide analogues as potential Chk1 inhibitors: Study of amino-platforms for their synthesis.
    Lavrard H; Rodriguez F; Delfourne E
    Bioorg Med Chem; 2014 Sep; 22(17):4961-7. PubMed ID: 25047935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition.
    Deslandes S; Chassaing S; Delfourne E
    Mar Drugs; 2009 Dec; 7(4):754-86. PubMed ID: 20098609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bis-imide granulatimide analogues as potent Checkpoint 1 kinase inhibitors.
    Hénon H; Messaoudi S; Anizon F; Aboab B; Kucharczyk N; Léonce S; Golsteyn RM; Pfeiffer B; Prudhomme M
    Eur J Pharmacol; 2007 Jan; 554(2-3):106-12. PubMed ID: 17134696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro antiproliferative activity of amido and amino analogues of the marine alkaloid isogranulatimide.
    Lavrard H; Salvetti B; Mathieu V; Rodriguez F; Kiss R; Delfourne E
    ChemMedChem; 2015 Apr; 10(4):607-9. PubMed ID: 25735892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activities of isogranulatimide analogues.
    Hugon B; Anizon F; Bailly C; Golsteyn RM; Pierré A; Léonce S; Hickman J; Pfeiffer B; Prudhomme M
    Bioorg Med Chem; 2007 Sep; 15(17):5965-80. PubMed ID: 17582773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide.
    Conchon E; Anizon F; Aboab B; Prudhomme M
    J Med Chem; 2007 Sep; 50(19):4669-80. PubMed ID: 17722905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of analogs of the marine alkaloids granulatimide and isogranulatimide.
    Deslandes S; Lamoral-Theys D; Frongia C; Chassaing S; Bruyère C; Lozach O; Meijer L; Ducommun B; Kiss R; Delfourne E
    Eur J Med Chem; 2012 Aug; 54():626-36. PubMed ID: 22809559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide.
    Jiang X; Zhao B; Britton R; Lim LY; Leong D; Sanghera JS; Zhou BB; Piers E; Andersen RJ; Roberge M
    Mol Cancer Ther; 2004 Oct; 3(10):1221-7. PubMed ID: 15486189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency switch between CHK1 and MK2: discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.
    Meng Z; Ciavarri JP; McRiner A; Zhao Y; Zhao L; Reddy PA; Zhang X; Fischmann TO; Whitehurst C; Arshad Siddiqui M
    Bioorg Med Chem Lett; 2013 May; 23(10):2863-7. PubMed ID: 23587425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of thienopyridinones as Chk1 inhibitors.
    Song P; Peng P; Han M; Cao X; Ma X; Liu T; Zhou Y; Hu Y
    Bioorg Med Chem; 2014 Sep; 22(17):4882-92. PubMed ID: 25042558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrolocarbazoles as checkpoint 1 kinase inhibitors.
    Hénon H; Conchon E; Hugon B; Messaoudi S; Golsteyn RM; Prudhomme M
    Anticancer Agents Med Chem; 2008 Aug; 8(6):577-97. PubMed ID: 18690823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues.
    Parrino B; Attanzio A; Spanò V; Cascioferro S; Montalbano A; Barraja P; Tesoriere L; Diana P; Cirrincione G; Carbone A
    Eur J Med Chem; 2017 Sep; 138():371-383. PubMed ID: 28688277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors.
    Tao ZF; Wang L; Stewart KD; Chen Z; Gu W; Bui MH; Merta P; Zhang H; Kovar P; Johnson E; Park C; Judge R; Rosenberg S; Sowin T; Lin NH
    J Med Chem; 2007 Apr; 50(7):1514-27. PubMed ID: 17352464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and SAR of thienopyridines as potent CHK1 inhibitors.
    Zhao L; Zhang Y; Dai C; Guzi T; Wiswell D; Seghezzi W; Parry D; Fischmann T; Siddiqui MA
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7216-21. PubMed ID: 21074424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B.
    Tahtouh T; Elkins JM; Filippakopoulos P; Soundararajan M; Burgy G; Durieu E; Cochet C; Schmid RS; Lo DC; Delhommel F; Oberholzer AE; Pearl LH; Carreaux F; Bazureau JP; Knapp S; Meijer L
    J Med Chem; 2012 Nov; 55(21):9312-30. PubMed ID: 22998443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, checkpoint kinase 1 inhibitory properties and in vitro antiproliferative activities of new pyrrolocarbazoles.
    Conchon E; Anizon F; Aboab B; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
    Bioorg Med Chem; 2008 Apr; 16(8):4419-30. PubMed ID: 18321713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of C-glycosyl pyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as a scaffold for check point kinase 1 inhibitors.
    Ichikawa S; Tatebayashi N; Matsuda A
    J Org Chem; 2013 Dec; 78(23):12065-75. PubMed ID: 24127858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 7-hydroxy-1H-benzoimidazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
    Shin D; Lee SC; Heo YS; Lee WY; Cho YS; Kim YE; Hyun YL; Cho JM; Lee YS; Ro S
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5686-9. PubMed ID: 17764934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Amino-2-arylamino-5-indoloyl/cinnamoythiazoles, analogs of topsentin-class of marine alkaloids, induce apoptosis in HeLa cells.
    Juneja M; Vanam U; Paranthaman S; Bharathan A; Keerthi VS; Reena JK; Rajaram R; Rajasekharan KN; Karunagaran D
    Eur J Med Chem; 2013 May; 63():474-83. PubMed ID: 23524113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors.
    Debdab M; Renault S; Lozach O; Meijer L; Paquin L; Carreaux F; Bazureau JP
    Eur J Med Chem; 2010 Feb; 45(2):805-10. PubMed ID: 19879673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.